CCO Oncology Podcast

189 Episodo

1. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom

   Publicado: 20/11/2020
2. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France

   Publicado: 19/11/2020
3. Molecular Classification of Endometrial Carcinoma in the Clinic Today

   Publicado: 11/11/2020
4. Advances in Immunotherapy for Endometrial Cancer

   Publicado: 11/11/2020
5. Developments in Acute Leukemias: Expert Answers to Clinician Questions

   Publicado: 2/10/2020
6. Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

   Publicado: 2/10/2020
7. Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond

   Publicado: 2/10/2020
8. Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

   Publicado: 21/9/2020
9. The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

   Publicado: 21/9/2020
10. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

    Publicado: 17/9/2020
11. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

    Publicado: 17/9/2020
12. Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC

    Publicado: 17/9/2020
13. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

    Publicado: 16/9/2020
14. CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

    Publicado: 14/9/2020
15. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

    Publicado: 8/9/2020
16. FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

    Publicado: 3/9/2020
17. New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

    Publicado: 1/9/2020
18. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

    Publicado: 31/8/2020
19. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

    Publicado: 31/8/2020
20. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

    Publicado: 28/8/2020